Skip to content

PP&E (Net) at other companies

Merck & Co. logo
Merck & Co.MRK
$25.43B+2.6%
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$157M+51.0%
LQD
Liquidia CorporationLQDA
$20.84M+146%
United Therapeutics logo
United TherapeuticsUTHR
$1.84B+41.3%

Other financials

Income statement

See full
Operating income-$14.9M-30.0%
Net income-$13.2M-27.6%
EPS (diluted)-$0.090.0%

Balance sheet

See full
Cash & equivalents$19.4M+0.2%
Total debt$682.0K-28.7%
Total equity$172.1M+73.1%
Total assets$179.6M+67.8%

Cash flow

See full
Operating cash flow-$16.7M-23.8%
CapEx$102.0K
Free cash flow-$16.8M

Valuation

See full
Market cap$2.47B+152%
Enterprise value$2.45B+157%

Returns & leverage

See full
Return on equity-33.6%-9.4pp
Debt / equity0.0×
Current ratio24.8×+9.4×

Where this comes from

Reported directly by Trevi Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trevi Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trevi Therapeutics, Inc.'s PP&E (net)?
Trevi Therapeutics, Inc. (TRVI) reported PP&E (net) of $265K in Q1 2026.
How has Trevi Therapeutics, Inc.'s PP&E (net) changed year-over-year?
Trevi Therapeutics, Inc.'s PP&E (net) decreased by 4.3% year-over-year, from $277K to $265K.
What is the long-term trend for Trevi Therapeutics, Inc.'s PP&E (net)?
Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s PP&E (net) has grown at a 11.6% compound annual growth rate (CAGR), from $103K to $178K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.